DayOne, Cortical Labs and NUS Medicine Launch Singapore's First Biological Data Center Prototype

SINGAPORE — In a landmark development for global digital infrastructure and next-generation computing, DayOne Data Centers Limited has officially launched Singapore's first Biological Data Center Prototype. Unveiled in collaboration with Cortical Labs and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), the initiative marks a definitive shift in how the technology sector addresses the staggering energy demands of artificial intelligence and hyperscale computing.

The high-profile launch brought together public sector leaders, academic pioneers, and heavyweights from the digital infrastructure community. Attendees were treated to a live demonstration of Cortical Labs' proprietary CL1 biological computing system, alongside an exclusive tour of the advanced NUS laboratory supporting the initiative. At the heart of the deployment is a 20-unit CL1 system—recognized globally as the first independently operated biologically integrated server rack—operating within a live research environment designed and maintained by DayOne.

Biological computing represents a paradigm shift away from traditional silicon-only architectures. By utilizing living human neurons grown from stem cells and interfacing them with silicon hardware, the system processes information through biological adaptation. These neurons receive electrical signals, respond, and dynamically evolve over time, allowing the infrastructure to perform complex computational tasks on a fraction of the wattage required by standard digital processors. This wetware approach offers a pragmatic pathway to scale AI workloads while dramatically lowering power intensity and thermal footprints.

The tripartite collaboration leverages the unique strengths of each participating entity. NUS Medicine contributes world-class neurobiology expertise through the Neurobiology Programme and the Neuroscience Translational Research Programme. Cortical Labs supplies its cutting-edge biological computing architecture, while DayOne brings its robust capabilities in designing and operating mission-critical digital infrastructure across its nine-market footprint in Asia Pacific and Europe, where it has secured roughly 2.1 GW of bookings since its inception in 2022.

Beyond general AI processing, the prototype will spearhead explorations into neuro-inspired artificial intelligence, advanced biomedical modeling, accelerated drug discovery, and neurological disease research. Leaders from all three organizations emphasized that the project transitions biological computing from theoretical academic research into tangible commercial application, specifically targeting domains where data scarcity and rapid adaptability are paramount.

The timing of the prototype's launch is strategically critical for Singapore, which is aggressively expanding its AI and cloud capacity under stringent energy and environmental guardrails. The initiative is tightly integrated with Singapore's Green Data Center Roadmap, setting elevated benchmarks for energy efficiency. For DayOne, this milestone reinforces its broader domestic commitments, running parallel to the structural topping out of its flagship local data center, SG1, in May 2026—slated to be operational by early 2027—and the development of its Global Operations Command Center in Singapore.

"The launch of Singapore's first biological data center prototype by DayOne, Cortical Labs, and NUS Medicine is a watershed moment for the global digital infrastructure and deep-tech ecosystem. As artificial intelligence workloads push conventional silicon hardware to its absolute thermal and energy limits, the industry is forced to look beyond traditional paradigms. Integrating living neural networks with silicon processing is no longer science fiction; it represents a commercially viable, highly energy-efficient frontier that redefines sustainability in computing. At StartupLanes, we closely monitor how pioneering infrastructure plays enable the next wave of technological revolutions. This convergence of biotechnology, neurobiology, and hyperscale engineering not only addresses Singapore's stringent green data center mandates but also unlocks unprecedented capabilities in drug discovery and neuro-inspired AI. It proves that future-forward venture investments and institutional collaborations must look toward biological innovation to solve our most pressing infrastructural bottlenecks on a global scale." — Dr. Shishir Gupta, Founder & CEO, StartupLanes